• Explore /
  • Poster
  • / PERSIST: A multicenter, randomized phase II trial of perioperative oxaliplatin and S-1 (SOX) with or without sintilimab in resectable locally advanced gastric/gastroesophageal junction cancer (GC/GEJC).

PERSIST: A multicenter, randomized phase II trial of perioperative oxaliplatin and S-1 (SOX) with or without sintilimab in resectable locally advanced gastric/gastroesophageal junction cancer (GC/GEJC).

Abstract Poster

Authors

null

Xuewei Ding

Department of Gastric Surgery, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China;

Xuewei Ding , Xuejun Wang , Bin Li , Longgang Wang , Honghai Guo , Liang Shang , Wenbai Huang , Liangliang Wu , Bin Ke , Yong Liu , Ning Liu , Baogui Wang , Mingzhi Cai , Jingyu Deng , Rupeng Zhang , Jiancheng Zhang , Jie Chai , Qun Zhao , Leping Li , Han Liang

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT04982939

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr 364)

DOI

10.1200/JCO.2023.41.4_suppl.364

Abstract #

364

Poster Bd #

F5

Abstract Disclosures

Similar Posters

First Author: Xuewei Ding

First Author: Mian Wang

First Author: Junwei Wu

First Author: Chenyu Mao